Press Releases

Propanc Confirms PRP Response to Broad Range of Cancer Indications; Sets Date for Scientific Advice Meeting with UK Regulators

Mar 2, 2016

Propanc Discovers PRP Dramatically Suppresses Cancer Stem Cells

Feb 4, 2016

Propanc Receives Additional $525,000 from Institutional Investor; Initiates Animal Safety Toxicology Studies for PRP

Jan 13, 2016

Propanc Raises Capital to Complete Next Round of Animal Studies

Mar 17, 2015

Propanc Helping to Unravel Mystery Associated with Carcinomas

Mar 11, 2015

Propanc Initiates Next Phase of R&D Activities

Feb 23, 2015

Propanc Announces Latest Company Initiatives

Jan 13, 2015

Propanc enters into $5 million Equity Purchase Agreement with Southridge Partners

Sep 22, 2014

Propanc Stock Now DWAC/FAST Eligible

Jul 18, 2014

Propanc Secures $400,000 Bridge Financing Through Private Placement

Jun 6, 2014